Springer Nature OA
open access
CC BY 4.0
PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials#991168
- GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer#321697
- GutCore: An Endoscopy Foundation Model for Whole-Case Gastric Cancer Analysis#459880
- Additional file 1 of eGDR and gastrointestinal cancer mortality in the UK Biobank: a prospective cohort study#658819
- Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial#825660
Record · ID 324001
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive